EtoposideCisplatinCarcinoma, Small CellAntineoplastic Combined Chemotherapy ProtocolsIfosfamideLung NeoplasmsDrug Administration ScheduleCarboplatinCombined Modality TherapyDisease-Free SurvivalTreatment OutcomeSurvival AnalysisVincristineCyclophosphamideDoxorubicinMitolactolSurvival RateAntineoplastic AgentsDeoxycytidineLeukopeniaVinblastinePaclitaxelFluorouracilCarcinoma, Non-Small-Cell LungInduction ChemotherapyAntineoplastic Agents, PhytogenicInfusions, IntravenousHead and Neck NeoplasmsCarcinoma, Squamous CellOvarian NeoplasmsTaxoidsNeoplasm StagingNeoplasm Recurrence, LocalDose-Response Relationship, DrugDrug Resistance, NeoplasmTopoisomerase II InhibitorsRadiotherapy, AdjuvantPlatinumChemotherapy, AdjuvantPodophyllotoxinBleomycinDNA Topoisomerases, Type IIFollow-Up StudiesApoptosisGerminomaPrognosisTesticular NeoplasmsCell Line, TumorCamptothecinProspective StudiesTumor Cells, CulturedDrug SynergismDNA DamageNeoplasms, Germ Cell and EmbryonalDrug Screening Assays, AntitumorAmsacrineNeutropeniaCytarabineDNA AdductsRemission InductionDrug EvaluationCell SurvivalVomitingDrug ResistanceTeniposideHematologic DiseasesThrombocytopeniaCarmustineSalvage Therapy